EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Depigmentation Therapy of Refractory Facial Vitiligo Using 532‐Nm Picosecond Laser: Two Case Reports and Literature Review

Xinxin Li, Xuhai Yuan iD, Juan Du, Xiaolan Ding iD, Fang Wang iD

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70604 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Xinxin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Vitiligo, Lasers, Solid-State, Low-Level Light Therapy, Facial Dermatoses. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vitiligo is a common depigmenting disorder resulting from the loss of functional melanocytes. In certain refractory cases, conventional therapies fail to achieve complete repigmentation, leaving residual pigmented macules that can be cosmetically undesirable.

Aims

To assess the efficacy and safety of 532‐nm picosecond laser combined with hydroquinone cream for treating residual pigmentation in vitiligo. Patients We report two patients with stable generalized vitiligo who received 532‐nm picosecond laser treatment for residual pigmented macules. Patients subsequently applied 2% hydroquinone cream for 1–2 months. Clinical outcomes and adverse events were recorded. Written informed consent was obtained from both patients.

Results

Marked reduction in residual pigmentation was observed in both patients, with cosmetically favorable outcomes. Mild erythema and burning sensation occurred immediately after treatment and resolved within 1 week.

Conclusions

The 532‐nm picosecond laser, followed by topical hydroquinone, appears to be an effective and well‐tolerated approach for managing residual pigmentation in vitiligo. This reverse depigmentation strategy may serve as a valuable adjunct to enhance skin tone uniformity in selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoLasers, Solid-StateLow-Level Light TherapyFacial DermatosesHumansHydroquinonesFemaleAdultTreatment OutcomeSkin PigmentationMaleMiddle AgedCombined Modality Therapy

Stichwörter der Autor:innen

532‐nm picoseconddepigmentation therapylaser therapyvitiligo

Substanzen

Hydroquinoneshydroquinone

Autor:innen und Institutionen

  • Department of Dermatology, Peking University People's Hospital, Beijing, China.

ORCID-Profile: Xuhai Yuan, Xiaolan Ding, Fang Wang

Förderung

  • Beijing Municipal Natural Science Foundation
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Li, X., Yuan, X., Du, J., Ding, X., & Wang, F. (2025). Depigmentation Therapy of Refractory Facial Vitiligo Using 532‐Nm Picosecond Laser: Two Case Reports and Literature Review. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70604

Vancouver

Li X, Yuan X, Du J, Ding X, Wang F. Depigmentation Therapy of Refractory Facial Vitiligo Using 532‐Nm Picosecond Laser: Two Case Reports and Literature Review. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70604

BibTeX
@article{Li2025,
  author = {Li, Xinxin and Yuan, Xuhai and Du, Juan and Ding, Xiaolan and Wang, Fang},
  title = {Depigmentation Therapy of Refractory Facial Vitiligo Using 532‐Nm Picosecond Laser: Two Case Reports and Literature Review},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70604}
}
Kostenlos starten →